These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8094888

  • 1. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Delannoy A, Hanique G, Ferrant A.
    N Engl J Med; 1993 Mar 18; 328(11):812; author reply 813. PubMed ID: 8094888
    [No Abstract] [Full Text] [Related]

  • 2. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Saven A, Lemon RH, Piro LD.
    N Engl J Med; 1993 Mar 18; 328(11):812-3. PubMed ID: 8094889
    [No Abstract] [Full Text] [Related]

  • 3. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
    Schirmer M, Michlmayr G, Geisen F, Konwalinka G.
    Leukemia; 1996 Jul 18; 10(7):1253-4. PubMed ID: 8684013
    [No Abstract] [Full Text] [Related]

  • 4. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G, Elmhorn-Rosenborg A, Liliemark J.
    N Engl J Med; 1992 Oct 08; 327(15):1056-61. PubMed ID: 1355853
    [Abstract] [Full Text] [Related]

  • 5. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Juliusson G, Liliemark J.
    N Engl J Med; 1994 Jun 23; 330(25):1828-9; author reply 1829-30. PubMed ID: 7910664
    [No Abstract] [Full Text] [Related]

  • 6. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Saven A, Piro L.
    N Engl J Med; 1994 Jun 23; 330(25):1829-30. PubMed ID: 7910665
    [No Abstract] [Full Text] [Related]

  • 7. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A.
    Semin Hematol; 1996 Jan 23; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract] [Full Text] [Related]

  • 8. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C, Hiddemann W.
    Leukemia; 1997 Apr 23; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [Abstract] [Full Text] [Related]

  • 9. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
    Tallman MS, Hakimian D.
    Semin Hematol; 1996 Jan 23; 33(1 Suppl 1):23-7. PubMed ID: 8714613
    [No Abstract] [Full Text] [Related]

  • 10. Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.
    O'Brien S, Kantarjian H, Estey E, Koller C, Robertson B, Beran M, Andreeff M, Pierce S, Keating M.
    N Engl J Med; 1994 Feb 03; 330(5):319-22. PubMed ID: 7904047
    [Abstract] [Full Text] [Related]

  • 11. Listeriosis after 2-chlorodeoxyadenosine treatment.
    Spielberger RT, Stock W, Larson RA.
    N Engl J Med; 1993 Mar 18; 328(11):813-4. PubMed ID: 8094890
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic lymphatic leukemia].
    Adam Z, Vorlícek J, Hejlová N.
    Vnitr Lek; 1996 Aug 18; 42(8):573-8. PubMed ID: 8967031
    [Abstract] [Full Text] [Related]

  • 13. New drugs in the treatment of chronic lymphocytic leukemia.
    Keating MJ, O'Brien S, Robertson L, Plunkett W, Kantarjian H, Koller C.
    Leukemia; 1992 Nov 18; 6 Suppl 4():140-1. PubMed ID: 1359203
    [No Abstract] [Full Text] [Related]

  • 14. Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
    Cheson BD.
    Semin Hematol; 1998 Jul 18; 35(3 Suppl 3):14-21. PubMed ID: 9685175
    [No Abstract] [Full Text] [Related]

  • 15. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Bouzar AB, Boxus M, Defoiche J, Berchem G, Macallan D, Pettengell R, Willis F, Burny A, Lagneaux L, Bron D, Chatelain B, Chatelain C, Willems L.
    Br J Haematol; 2009 Jan 18; 144(1):41-52. PubMed ID: 19006566
    [Abstract] [Full Text] [Related]

  • 16. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep 18; 34(879):89-90. PubMed ID: 1355592
    [No Abstract] [Full Text] [Related]

  • 17. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE.
    Henry Ford Hosp Med J; 1991 Sep 18; 39(2):98-102. PubMed ID: 1679757
    [Abstract] [Full Text] [Related]

  • 18. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun 18; 5(6):20. PubMed ID: 1831638
    [No Abstract] [Full Text] [Related]

  • 19. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F, Stelitano C, Callea I, Filangeri M, Oliva B, Sculli G, Callea V, Nobile F, Brugiatelli M.
    Haematologica; 1996 Jun 18; 81(3):224-31. PubMed ID: 8767527
    [Abstract] [Full Text] [Related]

  • 20. [Successful treatment for advanced and refractory chronic lymphocytic leukemia with fludarabine phosphate].
    Takeuchi M, Tada A, Soda R, Takahashi K.
    Rinsho Ketsueki; 1997 Sep 18; 38(9):792-4. PubMed ID: 9364873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.